CAMBIUM BIO LIMITED - Announcements

2.44%

40.0¢

Market Cap $7.313M

Healthcare Biotechnology

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CMB	CEO Appointment and Resignation	PRICE SENSITIVE	02/11/20	126KB	Share
CMB	Annual Report Additional Information		30/10/20	216.14KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	30/10/20	318.66KB	Share
CMB	Regeneus receives $5.6M milestone payment from Kyocera	PRICE SENSITIVE	29/10/20	122.45KB	Share
CMB	Results of Annual General Meeting		14/10/20	126.38KB	Share
CMB	AGM Chairman's Address and CEO Presentation		14/10/20	2.14MB	Share
CMB	Regeneus to be granted new Sygenus patent in Canada	PRICE SENSITIVE	07/10/20	135.28KB	Share
CMB	Australian Biomarker Patent Allowed		01/10/20	136.76KB	Share
CMB	Regeneus receives $676k in R&D Tax Incentives		29/09/20	123.14KB	Share
CMB	Notice of initial substantial holder - AGC Inc.		11/09/20	118.77KB	Share
CMB	Virtual Annual General Meeting Online Guide		11/09/20	717.53KB	Share
CMB	Notice of Annual General Meeting / Proxy / Question Form		11/09/20	558.62KB	Share
CMB	Issue of AGC shares complete		10/09/20	120.78KB	Share
CMB	Appendix 2A		10/09/20	276.06KB	Share
CMB	Cleansing Notice		10/09/20	100.45KB	Share
CMB	Notice of initial substantial holder - Kirman 2 Pty Ltd		08/09/20	158.72KB	Share
CMB	Appendix 3G		03/09/20	278.47KB	Share
CMB	Appendix 3Y - Leo Lee		03/09/20	223.88KB	Share
CMB	CEO bonus payment		03/09/20	123.19KB	Share
CMB	Regeneus receives milestone payment from Kyocera	PRICE SENSITIVE	28/08/20	131.33KB	Share
CMB	Appendix 4G and Corporate Governance Statement		28/08/20	271.45KB	Share
CMB	Appendix 4E and Annual Report	PRICE SENSITIVE	28/08/20	1.51MB	Share
CMB	Regeneus to present at FNN Virtual Investor Event	PRICE SENSITIVE	25/08/20	1.42MB	Share
CMB	US Patent for Sygenus	PRICE SENSITIVE	19/08/20	137.03KB	Share
CMB	Regeneus and Kyocera sign Progenza OA deal	PRICE SENSITIVE	11/08/20	184.71KB	Share
CMB	Trading Halt	PRICE SENSITIVE	07/08/20	147.71KB	Share
CMB	Date of AGM		05/08/20	317.18KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/20	300.13KB	Share
CMB	Progenza OA Kyocera negotiations update	PRICE SENSITIVE	28/07/20	111.68KB	Share
CMB	Appendix 3Z - Final Director's Interest Notice		04/06/20	127.69KB	Share
CMB	Director Resignation		04/06/20	121.36KB	Share
CMB	Kyocera completes Progenza Due Diligence	PRICE SENSITIVE	18/05/20	125.44KB	Share
CMB	Appendix 4C Updated	PRICE SENSITIVE	05/05/20	303.19KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	29/04/20	296.66KB	Share
CMB	Appendix 3G		01/04/20	272.89KB	Share
CMB	Regeneus to be granted new key Progenza patent in U.S.	PRICE SENSITIVE	23/03/20	151.7KB	Share
CMB	Regeneus receives A$1.6M milestone payment from Kyocera	PRICE SENSITIVE	20/03/20	133.92KB	Share
CMB	Regeneus signs MOU with Kyocera Corporation	PRICE SENSITIVE	02/03/20	158.67KB	Share
CMB	Half-Year Results & Business Update	PRICE SENSITIVE	28/02/20	181.02KB	Share
CMB	Appendix 4D and Half-Year Report	PRICE SENSITIVE	28/02/20	1.17MB	Share
CMB	Directors provide $4m loan facility	PRICE SENSITIVE	28/02/20	179.4KB	Share
CMB	Appendix 3Ys		06/02/20	498.33KB	Share
CMB	Appendix 3G		06/02/20	273.92KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	31/01/20	313.26KB	Share
CMB	Appendix 3G		20/01/20	273.05KB	Share
CMB	Proposed issue of Securities - RGS		20/12/19	25.01KB	Share
CMB	AGC Agreement termination paves way for commercial partner	PRICE SENSITIVE	20/12/19	172.04KB	Share
CMB	RGS receives Innovation Grant		18/12/19	127.26KB	Share
CMB	Results of the Annual General Meeting		21/11/19	2.91MB	Share
CMB	CEO Presentation to 2019 Annual General Meeting	PRICE SENSITIVE	21/11/19	819.25KB	Share
CMB	Chairman's Address to Shareholders	PRICE SENSITIVE	21/11/19	66.33KB	Share
CMB	Cleansing Statement		20/11/19	92.12KB	Share
CMB	Appendix 3B		20/11/19	467.56KB	Share
CMB	Japanese Biotech Fund takes up all Rights Issue Shortfall	PRICE SENSITIVE	19/11/19	135.62KB	Share
CMB	Response to ASX Appendix 4C Query	PRICE SENSITIVE	31/10/19	1005.4KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/19	297.16KB	Share
CMB	Appendix 4G and Corporate Governance Statement		30/10/19	314.33KB	Share
CMB	Annual Report 2019		30/10/19	1.15MB	Share
CMB	Notice of Annual General Meeting / Proxy Form		18/10/19	402.49KB	Share
CMB	Regeneus receives A$1.5 million in R&D Tax Incentives	PRICE SENSITIVE	15/10/19	99.45KB	Share
CMB	Change of Registered Office and Principal Place of Business		15/10/19	87.65KB	Share
CMB	Financial Report - Year Ended 30 June 2019		26/09/19	686.48KB	Share
CMB	Change of interests of substantial holder - Graham Vesey		11/09/19	201.32KB	Share
CMB	Notice of initial substantial holder - Leo Lee		11/09/19	130.24KB	Share
CMB	Date of AGM		10/09/19	90.08KB	Share
CMB	Appendix 3Y - Glen Richards		03/09/19	220.42KB	Share
CMB	Appendix 3Y - Leo Lee		03/09/19	216.52KB	Share
CMB	Appendix 3Y - Barry Sechos		03/09/19	221.4KB	Share
CMB	Appendix 3B		03/09/19	446.85KB	Share
CMB	Clarification to Announcement		30/08/19	109.2KB	Share
CMB	Rights Issue Shortfall Notice		30/08/19	63.57KB	Share
CMB	Appendix 4E	PRICE SENSITIVE	30/08/19	306.59KB	Share
CMB	Confirmation of Despatch of Offer Booklet		13/08/19	1.42MB	Share
CMB	Restructuring results in 50% reduction in operating costs	PRICE SENSITIVE	13/08/19	129.96KB	Share
CMB	Placement Appendix 3B and Cleansing Statement		07/08/19	540.14KB	Share
CMB	Updated Investor Presentation	PRICE SENSITIVE	07/08/19	612.85KB	Share
CMB	Letter to Shareholders - Non Renounceable Rights Issue		02/08/19	1.21MB	Share
CMB	Letter to Option holders		01/08/19	255.25KB	Share
CMB	Cleansing Notice		01/08/19	346.34KB	Share
CMB	Appendix 3B		01/08/19	456.04KB	Share
CMB	Offer Booklet	PRICE SENSITIVE	01/08/19	1.31MB	Share
CMB	Investor Presentation	PRICE SENSITIVE	01/08/19	624.27KB	Share
CMB	Successful Private Placement	PRICE SENSITIVE	01/08/19	125.64KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	31/07/19	224.56KB	Share
CMB	Trading Halt	PRICE SENSITIVE	30/07/19	378.14KB	Share
CMB	Positive results for Progenza in treating neuropathic pain	PRICE SENSITIVE	23/07/19	143.49KB	Share
CMB	New Strategy To Deliver Therapies For Global Pain Market		22/07/19	142.4KB	Share
CMB	Appendix 3X - Initial Director's Interest Notice		02/05/19	199.02KB	Share
CMB	Appendix 3Z - Final Director's Interest Notice		02/05/19	201.75KB	Share
CMB	Regeneus Appoints International Directors for Global Growth		29/04/19	90.47KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	11/04/19	438.84KB	Share
CMB	Appendix 4D and Half-Year Report	PRICE SENSITIVE	28/02/19	1.34MB	Share
CMB	Directors Provide $2.5M Loan to Extend Funding Runway	PRICE SENSITIVE	28/02/19	65KB	Share
CMB	Response to ASX Appendix 4C Query Letter	PRICE SENSITIVE	22/02/19	657.35KB	Share
CMB	Material Terms of Contract for Chief Executive Officer		01/02/19	36.49KB	Share
CMB	Appendix 4C - Quarterly	PRICE SENSITIVE	30/01/19	239.42KB	Share
CMB	New CEO Appointed to Accelerate Global Growth	PRICE SENSITIVE	23/01/19	69.59KB	Share
CMB	Chinese patent granted for biomarkers for stem cell therapy	PRICE SENSITIVE	03/12/18	77.36KB	Share
CMB	Results of Annual General Meeting		22/11/18	404.1KB	Share
CMB	CEO Presentation to 2018 Annual General Meeting		22/11/18	1.64MB	Share

CMB CEO Appointment and Resignation
02/11/20	PRICE SENSITIVE	126KB	Share
CMB Annual Report Additional Information
30/10/20		216.14KB	Share
CMB Appendix 4C - Quarterly
30/10/20	PRICE SENSITIVE	318.66KB	Share
CMB Regeneus receives $5.6M milestone payment from Kyocera
29/10/20	PRICE SENSITIVE	122.45KB	Share
CMB Results of Annual General Meeting
14/10/20		126.38KB	Share
CMB AGM Chairman's Address and CEO Presentation
14/10/20		2.14MB	Share
CMB Regeneus to be granted new Sygenus patent in Canada
07/10/20	PRICE SENSITIVE	135.28KB	Share
CMB Australian Biomarker Patent Allowed
01/10/20		136.76KB	Share
CMB Regeneus receives $676k in R&D Tax Incentives
29/09/20		123.14KB	Share
CMB Notice of initial substantial holder - AGC Inc.
11/09/20		118.77KB	Share
CMB Virtual Annual General Meeting Online Guide
11/09/20		717.53KB	Share
CMB Notice of Annual General Meeting / Proxy / Question Form
11/09/20		558.62KB	Share
CMB Issue of AGC shares complete
10/09/20		120.78KB	Share
CMB Appendix 2A
10/09/20		276.06KB	Share
CMB Cleansing Notice
10/09/20		100.45KB	Share
CMB Notice of initial substantial holder - Kirman 2 Pty Ltd
08/09/20		158.72KB	Share
CMB Appendix 3G
03/09/20		278.47KB	Share
CMB Appendix 3Y - Leo Lee
03/09/20		223.88KB	Share
CMB CEO bonus payment
03/09/20		123.19KB	Share
CMB Regeneus receives milestone payment from Kyocera
28/08/20	PRICE SENSITIVE	131.33KB	Share
CMB Appendix 4G and Corporate Governance Statement
28/08/20		271.45KB	Share
CMB Appendix 4E and Annual Report
28/08/20	PRICE SENSITIVE	1.51MB	Share
CMB Regeneus to present at FNN Virtual Investor Event
25/08/20	PRICE SENSITIVE	1.42MB	Share
CMB US Patent for Sygenus
19/08/20	PRICE SENSITIVE	137.03KB	Share
CMB Regeneus and Kyocera sign Progenza OA deal
11/08/20	PRICE SENSITIVE	184.71KB	Share
CMB Trading Halt
07/08/20	PRICE SENSITIVE	147.71KB	Share
CMB Date of AGM
05/08/20		317.18KB	Share
CMB Appendix 4C - Quarterly
31/07/20	PRICE SENSITIVE	300.13KB	Share
CMB Progenza OA Kyocera negotiations update
28/07/20	PRICE SENSITIVE	111.68KB	Share
CMB Appendix 3Z - Final Director's Interest Notice
04/06/20		127.69KB	Share
CMB Director Resignation
04/06/20		121.36KB	Share
CMB Kyocera completes Progenza Due Diligence
18/05/20	PRICE SENSITIVE	125.44KB	Share
CMB Appendix 4C Updated
05/05/20	PRICE SENSITIVE	303.19KB	Share
CMB Appendix 4C - Quarterly
29/04/20	PRICE SENSITIVE	296.66KB	Share
CMB Appendix 3G
01/04/20		272.89KB	Share
CMB Regeneus to be granted new key Progenza patent in U.S.
23/03/20	PRICE SENSITIVE	151.7KB	Share
CMB Regeneus receives A$1.6M milestone payment from Kyocera
20/03/20	PRICE SENSITIVE	133.92KB	Share
CMB Regeneus signs MOU with Kyocera Corporation
02/03/20	PRICE SENSITIVE	158.67KB	Share
CMB Half-Year Results & Business Update
28/02/20	PRICE SENSITIVE	181.02KB	Share
CMB Appendix 4D and Half-Year Report
28/02/20	PRICE SENSITIVE	1.17MB	Share
CMB Directors provide $4m loan facility
28/02/20	PRICE SENSITIVE	179.4KB	Share
CMB Appendix 3Ys
06/02/20		498.33KB	Share
CMB Appendix 3G
06/02/20		273.92KB	Share
CMB Appendix 4C - Quarterly
31/01/20	PRICE SENSITIVE	313.26KB	Share
CMB Appendix 3G
20/01/20		273.05KB	Share
CMB Proposed issue of Securities - RGS
20/12/19		25.01KB	Share
CMB AGC Agreement termination paves way for commercial partner
20/12/19	PRICE SENSITIVE	172.04KB	Share
CMB RGS receives Innovation Grant
18/12/19		127.26KB	Share
CMB Results of the Annual General Meeting
21/11/19		2.91MB	Share
CMB CEO Presentation to 2019 Annual General Meeting
21/11/19	PRICE SENSITIVE	819.25KB	Share
CMB Chairman's Address to Shareholders
21/11/19	PRICE SENSITIVE	66.33KB	Share
CMB Cleansing Statement
20/11/19		92.12KB	Share
CMB Appendix 3B
20/11/19		467.56KB	Share
CMB Japanese Biotech Fund takes up all Rights Issue Shortfall
19/11/19	PRICE SENSITIVE	135.62KB	Share
CMB Response to ASX Appendix 4C Query
31/10/19	PRICE SENSITIVE	1005.4KB	Share
CMB Appendix 4C - Quarterly
31/10/19	PRICE SENSITIVE	297.16KB	Share
CMB Appendix 4G and Corporate Governance Statement
30/10/19		314.33KB	Share
CMB Annual Report 2019
30/10/19		1.15MB	Share
CMB Notice of Annual General Meeting / Proxy Form
18/10/19		402.49KB	Share
CMB Regeneus receives A$1.5 million in R&D Tax Incentives
15/10/19	PRICE SENSITIVE	99.45KB	Share
CMB Change of Registered Office and Principal Place of Business
15/10/19		87.65KB	Share
CMB Financial Report - Year Ended 30 June 2019
26/09/19		686.48KB	Share
CMB Change of interests of substantial holder - Graham Vesey
11/09/19		201.32KB	Share
CMB Notice of initial substantial holder - Leo Lee
11/09/19		130.24KB	Share
CMB Date of AGM
10/09/19		90.08KB	Share
CMB Appendix 3Y - Glen Richards
03/09/19		220.42KB	Share
CMB Appendix 3Y - Leo Lee
03/09/19		216.52KB	Share
CMB Appendix 3Y - Barry Sechos
03/09/19		221.4KB	Share
CMB Appendix 3B
03/09/19		446.85KB	Share
CMB Clarification to Announcement
30/08/19		109.2KB	Share
CMB Rights Issue Shortfall Notice
30/08/19		63.57KB	Share
CMB Appendix 4E
30/08/19	PRICE SENSITIVE	306.59KB	Share
CMB Confirmation of Despatch of Offer Booklet
13/08/19		1.42MB	Share
CMB Restructuring results in 50% reduction in operating costs
13/08/19	PRICE SENSITIVE	129.96KB	Share
CMB Placement Appendix 3B and Cleansing Statement
07/08/19		540.14KB	Share
CMB Updated Investor Presentation
07/08/19	PRICE SENSITIVE	612.85KB	Share
CMB Letter to Shareholders - Non Renounceable Rights Issue
02/08/19		1.21MB	Share
CMB Letter to Option holders
01/08/19		255.25KB	Share
CMB Cleansing Notice
01/08/19		346.34KB	Share
CMB Appendix 3B
01/08/19		456.04KB	Share
CMB Offer Booklet
01/08/19	PRICE SENSITIVE	1.31MB	Share
CMB Investor Presentation
01/08/19	PRICE SENSITIVE	624.27KB	Share
CMB Successful Private Placement
01/08/19	PRICE SENSITIVE	125.64KB	Share
CMB Appendix 4C - Quarterly
31/07/19	PRICE SENSITIVE	224.56KB	Share
CMB Trading Halt
30/07/19	PRICE SENSITIVE	378.14KB	Share
CMB Positive results for Progenza in treating neuropathic pain
23/07/19	PRICE SENSITIVE	143.49KB	Share
CMB New Strategy To Deliver Therapies For Global Pain Market
22/07/19		142.4KB	Share
CMB Appendix 3X - Initial Director's Interest Notice
02/05/19		199.02KB	Share
CMB Appendix 3Z - Final Director's Interest Notice
02/05/19		201.75KB	Share
CMB Regeneus Appoints International Directors for Global Growth
29/04/19		90.47KB	Share
CMB Appendix 4C - Quarterly
11/04/19	PRICE SENSITIVE	438.84KB	Share
CMB Appendix 4D and Half-Year Report
28/02/19	PRICE SENSITIVE	1.34MB	Share
CMB Directors Provide $2.5M Loan to Extend Funding Runway
28/02/19	PRICE SENSITIVE	65KB	Share
CMB Response to ASX Appendix 4C Query Letter
22/02/19	PRICE SENSITIVE	657.35KB	Share
CMB Material Terms of Contract for Chief Executive Officer
01/02/19		36.49KB	Share
CMB Appendix 4C - Quarterly
30/01/19	PRICE SENSITIVE	239.42KB	Share
CMB New CEO Appointed to Accelerate Global Growth
23/01/19	PRICE SENSITIVE	69.59KB	Share
CMB Chinese patent granted for biomarkers for stem cell therapy
03/12/18	PRICE SENSITIVE	77.36KB	Share
CMB Results of Annual General Meeting
22/11/18		404.1KB	Share
CMB CEO Presentation to 2018 Annual General Meeting
22/11/18		1.64MB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 40.0¢		Change -0.010(2.44%)		Mkt cap ! $7.313M

Open	High	Low	Value	Volume
41.0¢	41.0¢	40.0¢	$1.181K	2.912K

Buyers (Bids)

No.	Vol.	Price($)
1	1500	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
41.0¢	2441	1

View Market Depth

No.	Vol.	Price($)
1	1500	0.370
1	10000	0.340
1	20000	0.280
1	25000	0.270
1	9883	0.260

Price($)	Vol.	No.
0.410	2441	1
0.445	30	1
0.450	6000	1
0.455	550	1
0.480	4936	1

Last trade - 16.10pm 12/08/2025 (20 minute delay)

CMB (ASX) Chart

CAMBIUM BIO LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available